EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS111-02189 
Organism
Homo sapiens 
Tissue/cell
KB 
Coordinate
chr17:38676940-38679530 
Target genes
TF binding sites/motifs
Number: 9             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:38677494-38677512GGAAGGAGAGAAGGAGGC+6.3
FOSL2MA0478.1chr17:38678116-38678127CTGAGTCACCC-6.02
FOXP1MA0481.2chr17:38678729-38678741AAGTAAACAGAG+6.37
FOXP2MA0593.1chr17:38678729-38678740AAGTAAACAGA+6.32
HLTFMA0109.1chr17:38678288-38678298AACCTTATAT+6.02
JUNBMA0490.1chr17:38678116-38678127CTGAGTCACCC-6.02
Six3MA0631.1chr17:38679072-38679089ATAAGTGATACCCCTAA-6.16
ZNF263MA0528.1chr17:38677157-38677178CCCTCTCCATCCTCCTGCACC-6.26
ZNF263MA0528.1chr17:38678569-38678590GGAGGAGAGAGAGAGAGGGAA+6.92
Number of super-enhancer constituents: 25             
IDCoordinateTissue/cell
SE_25403chr17:38677049-38678581DND41
SE_25943chr17:38677342-38679664Duodenum_Smooth_Muscle
SE_26577chr17:38677003-38680122Esophagus
SE_32359chr17:38678872-38679504Gastric
SE_33816chr17:38677140-38679987HCC1954
SE_34508chr17:38676835-38678814HCT-116
SE_34641chr17:38671059-38680170HeLa
SE_35821chr17:38672181-38681376HMEC
SE_44181chr17:38676926-38678564NHDF-Ad
SE_45551chr17:38676708-38679830Osteoblasts
SE_51567chr17:38677316-38679666Skeletal_Muscle
SE_52624chr17:38677264-38678754Small_Intestine
SE_52624chr17:38678838-38679496Small_Intestine
SE_53520chr17:38677181-38678706Spleen
SE_55173chr17:38677443-38677883Thymus
SE_55173chr17:38678876-38679510Thymus
SE_56221chr17:38677033-38678770u87
SE_56976chr17:38676660-38679832VACO_400
SE_57448chr17:38676954-38678711VACO_503
SE_57448chr17:38678895-38679616VACO_503
SE_58835chr17:38672665-38782311Ly3
SE_61495chr17:38672564-38757231Toledo
SE_62232chr17:38671160-38782171Tonsil
SE_64249chr17:38672349-38680138NHEK
SE_67770chr17:38677033-38678770u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr173867773638678132
Number: 1             
IDChromosomeStartEnd
GH17I040515chr173867153438681110
Enhancer Sequence
AATCCTTATT TAATAACAAT CAACAGAACA GGATTATGAA CCGACACCAT ACAGAGGTAT 60
TTGTAAGAAA GAAGGTGGAT GCCGGAATCC TTTCTTCAAA CAGAAGCTTA CCAGTAAGTG 120
CAGACTAATA CAACAGGTAG GTCAAGGCTA ATCCAGTTGG AGGGGGTGCT GGTGGAGGTG 180
GGCACTGAGG GAGGGGGTCA GCACCCTAGC CGTCCAGCCC TCTCCATCCT CCTGCACCCG 240
CCACACCTGG GTTCTGTGCA GCCTGATGTG TCCCCACCCC CTCCTATGCA ATGAAGGAGG 300
GAGACGCAGA GATGGAGGGC GGCTTCCCCA AGACCACCCA GGGTACTGGT TTGTGGTGGA 360
GCGGGAAGAG GTCACGACGC CTCCTGCCTA GCACTCCCTC TCTTACCCCA GCCTGTCTGT 420
TGCCGCCTGC ATCCCTCCAT TCACACAGTG TCTTCTCCTG CCAGACACCA GCAGGACACA 480
GCGGGCAGGA CAGGTTCCTC TGGGTCTGCC CGAAGGACTC AAAGTCCAGG GACAAGAGTC 540
GCTTGGTGGC CTCAGGAAGG AGAGAAGGAG GCACTGTTTC GGATGGGCCG GGGGAAGTGG 600
AGGTGGGATG CAGGGCTGTG GAGTCCTCCT GGCAGCCTAG GCTGTGTGTG GGGCGTGGCG 660
GGATGCCAGA GGGTCTGTGT TGAGGCCTAG CCCTGTCTCC TCTACAGTGG AGGAACTGCT 720
TTGGGACTCA GTTTTGTTAC TTGTAAAATG GGGCCACGCT CTGCCCTTCC AGCTTCATGT 780
TGCTGAAGGG AGGCTCTAAG GAGACGGAAG CTTCCTGTTC CTGTAACAAG ATGCCATGAG 840
CGAATCATAC TCTCAGCCTG GCCCCCAGGA GTCTCCTCCC TTCGGGCTTC TGGAGTTCCC 900
TGCTCCACTC TGACCCCCAG GGAGAGTCCC CACGTATCCT CCCCGCTGTG GAGGGTGCCC 960
TTGCAGTCCT CCCTGAGCTG CCCCAGGATG ACTGGCTCCA CAGGGAATGT CCTCCCACTC 1020
TGTAGGAAGT GGAGCATGGC TGAGAAGAAC TCCCTGTGGT CAGGTCACCC CCATCCCCAG 1080
ACGCACACAG ACACAAACAC ATACATATCC TGAGGTATTG AAGAAGAATT CACCACACCC 1140
TGAAGATTGC TTTCCACAAA GCACTCTCTC CAAGCCCTGA GTCACCCAAC TCCTTCACTC 1200
TGGACACCCT GCCAGGAACA AGGATATTTG TCCTTTCGGC AGACATGGGT TCAAGTCCCT 1260
GCTCCACTGC TAACTAATGG CATGGCCTGG GTCAAGCATT ACTTGCTAAT CTCAGTTTTT 1320
TCATAGGTAG AATAAGGATA ATAGCATCAA CCTTATATGT TGGTTGTGAG GATCAAGTGA 1380
GATAATGTGT GTGTGGCAGG AGGAAAGCCA TCGGCGGGGG CGGGTGGGGG TCGAGTGTTC 1440
CATCCCAGTC TCTCCCTTCT CTCTGCTCAT CAGAGAAAAT CCTGACTTGG CCTATTTGAA 1500
TTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GCGCGCACGC 1560
CTCCCTTAAC CCTCTATGAA AGGTGCTGAT TTATTGGAAT AGTCCTTAGG CATAGGCGAT 1620
ATAGAACTGG GAGGAGAGAG AGAGAGGGAA GAAGGATTAG CAGCAAGACT GAGGGAGGAG 1680
GGAGGTTTGA GCAGCTGTAA TGGGTGAGGG AAGAGAGTGG GTGGGAGAAA GGAGATTTGA 1740
GAAGCATCGC TATGATCCAT GAATCTTTGT AGTCAAGTTT AAGAAATTCA AGTAAACAGA 1800
GTTATTGTGA AATTATTATT TTTTGGTTGC TATTCTCTCT CTCCTCTCCC ACTCTGTCTC 1860
TTTTTTTTTT TCTTTGAGAT GGGATCTTGC TCTGTCGCCT AGGCTGGAGT GACGCAGTGG 1920
TGAGATCATA GCTCACTGCA GCCAATTTTT TTTTGTAGCA ACAGGGTCTT GTTATATTGC 1980
CCAGGGTGGT CTCAAACTCC TGGCTTCAAG TGATCTTCCT GCCTTAGCCT CCCAAAGTGC 2040
TGGGATTACA GGCATGAGCT ACTGCGCCCA GCCTGGTTGC CATCCTTGAT GATAACGCAG 2100
CTTTGAGACT GGACCATTTG CATGACGGCC TTATAAGTGA TACCCCTAAG TAACATGCTT 2160
AGCACACAGT AGGGACACAG TAGGCACAGT GACTGGTGCT GTATCCTCTC AATTTGGATG 2220
ACACTTGTGT GCACATGTAC TGTCTCCCAT ATTGGACTGG GTGTTTCCTG AGTGTGGGTT 2280
GGATCACATC AGCCTGGGAG CGACTTGAAG CCTGGGACTC TATTTTGTTT CCCTGCCCTC 2340
CCACCCCCCG CCATATTAGA TGAGAAGCTC CTTGAGGACA GGGATTCTTC CTGTCCTGCT 2400
TTCTTCATTA GACCTGCAAC TCCCAGTGTG GGTGATGCTC TTCCTCCTTT TGGCTCTGCT 2460
CGAGGACTGA GAACAGGATC CTGCTCACAG ACTGTGTCTT AGACCCACCT GCCTTGGCCT 2520
CCCAGAGTGC TGGGATCACA GGCGTGAGCC ACCGCACCTG GCCATGATAG CTTGGCTTTC 2580
ATATCTCTGC 2590